Events

MEDraysintell will be attending several major Events-Congresses in 2018.

EANM, SNMMI, ESTRO, ASTRO.. .

EANM 2018

October 13-17, 2018
Düsseldorf, Germany

Come and see us on The Belgian Pavilion booth-14

http://eanm18.eanm.org/

 

News

July 16, 2018
MEDraysintell releases the fifth edition of its Nuclear Medicine Report and Directory

New radiotheranostics under development might lead to much stronger market figures than expected in coming years.

... read full story

June 20, 2018
Serge Goossens joins MEDraysintell as co-author & advisor
A new report and directory about radioactive material transport and handling under preparation

Serge Goossens joins MEDraysintell as co-author and advisor and brings his extended experience in the field of transport and handling of radiopharmaceuticals.

... read full story

February 1, 2018
Most promising radiopharmaceuticals on the market by 2024-2026

MEDraysintell releases a new report covering the most promising radiopharmaceuticals (radiodiagnostics, radiotherapeutics and radiotheranostics) currently in clinical stage development which have the highest chances to reach the market by 2024-2026.

... read full story

January 17, 2018
Proton Therapy Industry, a first consolidation in a niche market

With the recent announcement of Hitachi to acquire the particle therapy business of Mitsubishi, we observe the first consolidation in the PT industry. Following this recent announcement, the top three vendors share now 70% of the PT market in 2017 valued at US$ 0.9 billion.

... read full story

November 30, 217
MEDraysintell downgrades its proton therapy market projection

In light of several factors, MEDraysintell is downgrading its proton therapy market projection from 1,200 proton therapy treatment rooms that were expected to be operational in 2030 to 900. This still represents a 12% annual growth from 2017 to 2030 and the need to open an average of more than 50 PT treatment rooms every year from 2018 to 2030.

... read full story

June 2017
How fast will the U.S. market get access to Ga-68?

Article co-autored by Paul-Emmanuel Goethals and Dr. Richard Zimmermann, in DOTmed HealthCare Business News magazine, June 2017.
www.dotmed.com

... read full story

June 2016

Gallium-68, Lutetium-177, gain in the pharmaceutical world

Article co-autored by Paul-Emmanuel Goethals and Dr. Richard Zimmermann, in DOTmed HealthCare Business News magazine, June 2016.
www.dotmed.com

... read full story

March 16, 2016

Brachytherapy market to growth by 8% to 2030, new vendors and new products to come

The global brachytherapy industry is evaluated in a new and updated MEDraysintell’s report and directory, providing in a 340-page document a complete description of the radionuclides and devices used in brachytherapy, and a detailed profile of 62 companies and institutions active in this field around the world.

... read full story

December 3, 2015

MEDraysintell identifies more than 1,200 medical cyclotrons worldwide

MEDraysintell releases its new and unique report “Cyclotrons used in Nuclear Medicine, World Market Report & Directory, Edition 2015” that describes more than 1,200 medical cyclotrons worldwide.

... read full story

© Copyright 2018  MEDraysintell